文献速递肝病消化道肿瘤与早癌消化内镜

细胞外对比剂MRI检测肝细胞癌的准确性优于钆塞酸增强MRI或CT

Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-12-13

一项前瞻性研究纳入125例慢性肝病患者,比较CT、细胞外对比剂MRI(ECA-MRI)和肝细胞特异性对比剂MRI(HBA-MRI)基于LI-RADS检测肝细胞癌(HCC)的诊断性能。结果显示ECA-MRI的敏感性和准确性显著高于CT和HBA-MRI,且CT联合MRI可进一步提高诊断性能。

要点

  • ECA-MRI检测HCC的敏感性为83.1%,准确性为86.6%,均显著高于CT和HBA-MRI。
  • 所有技术的特异性均为97.4%,但ECA-MRI在显示动脉期高强化和强化包膜方面更具优势。
  • CT联合ECA-MRI或HBA-MRI可显著提高诊断敏感性,优于单独MRI。

核心结论

  • 在慢性肝病伴超声检出结节的患者中,基于LI-RADS,ECA-MRI检测HCC的敏感性和准确性显著高于CT或HBA-MRI;CT联合MRI诊断性能最佳。

研究设计与样本

  • 前瞻性研究纳入125例慢性肝病患者(102例男性,平均年龄55.3岁),在手术前接受CT、ECA-MRI或HBA-MRI检查,基于LI-RADS v2018评估诊断性能。

主要发现

  • 共分析163个病灶(124个HCC,13个非HCC恶性肿瘤,26个良性病变),平均大小20.7 mm。
  • ECA-MRI检测HCC的敏感性83.1%、准确性86.6%,显著高于CT(64.4%、71.8%,P < .001)和HBA-MRI(71.2%、76.5%,P = .005)。
  • 所有技术的特异性均为97.4%。
  • ECA-MRI显示动脉期高强化的比例为97.6%,显著高于CT(81.5%,P < .001)和HBA-MRI(89.5%,P = .002)。
  • ECA-MRI显示强化包膜的比例为85.5%,显著高于CT(33.9%,P < .001)和HBA-MRI(41.4%,P < .001)。

关键数值与推荐

  • CT联合ECA-MRI的敏感性89.2%、准确性91.4%(P < .05);CT联合HBA-MRI的敏感性82.8%、准确性86.5%(P < .05),均显著优于单独MRI。
  • ECA-MRI显示非周边廓清的比例为79.8%,CT为74.2%,HBA-MRI为73.4%,差异无统计学意义。

临床怎么用

  • 对于超声检出结节且需明确HCC诊断的慢性肝病患者,优先考虑ECA-MRI。
  • 若条件允许,CT联合MRI(尤其是ECA-MRI)可提高HCC检出准确性。

局限性

  • 单中心研究,样本量有限,结果需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Computed tomography (CT) and magnetic resonance imaging (MRI) are used to detect hepatocellular carcinoma (HCC). We performed a prospective study to compare the diagnostic performance of CT, MRI with extracellular contrast agents (ECA-MRI), and MRI with hepatobiliary agents (HBA-MRI) in the detection of HCC using the liver imaging reporting and data system (LI-RADS). METHODS: We studied 125 participants (102 men; mean age, 55.3 years) with chronic liver disease who underwent CT, ECA-MRI, or HBA-MRI (with gadoxetic acid) before surgery for a nodule initially detected by ultrasound at a tertiary center in Korea, from November 2016 through February 2019. We collected data on major features and assigned LI-RADS categories (v2018) from CT and MRI examinations. We then compared the diagnostic performance for LR-5 for each modality alone, and in combination. RESULTS: In total, 163 observations (124 HCCs, 13 non-HCC malignancies, and 26 benign lesions; mean size, 20.7 mm) were identified. ECA-MRI detected HCC with 83.1% sensitivity and 86.6% accuracy, compared to 64.4% sensitivity and 71.8% accuracy for CT (P < .001) and 71.2% sensitivity (P = .005) and 76.5% accuracy for HBA-MRI (P = .005); all technologies detected HCC with 97.4% specificity. Adding CT to either ECA-MRI (89.2% sensitivity, 91.4% accuracy; both P < .05) or HBA-MRI (82.8% sensitivity, 86.5% accuracy; both P < .05) significantly increased its diagnostic performance in detection of HCC compared with the MRI technologies alone. ECA-MRI identified arterial phase hyperenhancement in a significantly higher proportion of patients (97.6%) than CT (81.5%; P < .001) or HBA-MRI (89.5%; P = .002). ECA-MRI identified non-peripheral washout in 79.8% of patients, vs 74.2% of patients for CT and 73.4% of patients for HBA-MRI (differences not significant). ECA-MRI identified enhancing capsules in 85.5% of patients, vs 33.9% for CT (P < .001) and 41.4% for HBA-MRI (P < .001). CONCLUSION: In a prospective study of patients with chronic liver disease and a nodule detected by ultrasound, ECA-MRI detected HCC with higher levels of sensitivity and accuracy than CT or HBA-MRI, based on LI-RADS. Diagnostic performance was best when CT was used in combination with MRI compared with MRI alone.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Min JH, Kim JM, Kim YK, et al. Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography. Clin Gastroenterol Hepatol. 2019. PMID: 31843599. doi:10.1016/j.cgh.2019.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。